BridgeMD
Tests treatment safety and results for Hemiplegic Shoulder Pain
Official title Efficacy of Suprascapular Radiofrequency Ablation in Hemiplegic Shoulder Pain
ClinicalTrials.gov ID: NCT06473389
What this study is testing
- What it's testing
- Stroke, one of the most important causes of disability and death in the world, is an acute focal deficit of the central system caused by vascular origin such as cerebral infarction, intracerebral haemorrhage and subarachnoid haemorrhage. Hemiplegic shoulder pain, which is one of the most common complications after stroke, is an important problem affecting extremity rehabilitation.
- Which group you join is decided by chance.
A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.
Who can take part
Ages 18 and older
You may be able to join if
- Being over 18 years old
- Those who were diagnosed with hemorrhagic or ischemic stroke at least 3 months ago
- Patients with shoulder pain with VAS \> 5 severity after hemiplegia
- Those who agree to participate with a consent document (their own or their foster family)
You likely can't join if
- Those who did not provide a consent document
- Those under 18 years of age
- Those who cannot cooperate
- Severely aphasic patients
- Patients with shoulder pain VAS \>5 severity
- Patients who have undergone treatment procedures such as RF, suprascapular nerve blockade, steroid injection, etc. for the shoulder area in the last...
See the full eligibility criteria
- Being over 18 years old
- Those who were diagnosed with hemorrhagic or ischemic stroke at least 3 months ago
- Patients with shoulder pain with VAS \> 5 severity after hemiplegia
- Those who agree to participate with a consent document (their own or their foster family)
- Those who did not provide a consent document
- Those under 18 years of age
- Those who cannot cooperate
- Severely aphasic patients
- Patients with shoulder pain VAS \>5 severity
- Patients who have undergone treatment procedures such as RF, suprascapular nerve blockade, steroid injection, etc. for the shoulder area in the last 3 months
- Patients with bleeding diathesis
- Those with a history of surgery or radiotherapy in the shoulder area
- Those who had shoulder complaints before the stroke
- Patients with pacemakers
- Patients with MMT Score \<24
The study team makes the final eligibility decision.
Where it's taking place
- Ankara, Yenimahalle, Turkey (Türkiye)
Questions & answers
Do participants get paid in this trial?
This listing doesn't specify compensation. Many trials still reimburse travel or offer a stipend, so it's worth asking the study team when you connect.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part - confirm specifics with the study team.
How long does this study last?
The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.
Who can join this trial?
This study is enrolling all sexes, 18 years and older. The study team makes the final eligibility decision.
Where is this trial taking place?
Study sites include Ankara, Yenimahalle, Turkey (Türkiye). Enter your location above to see the nearest site and check your eligibility.
Explore other conditions
BridgeMD is an information and trial-matching tool - not medical advice, and not the study sponsor. Details come from ClinicalTrials.gov; the study team decides eligibility.